An observational study in Health Status, sponsored by Dr. Santiago Palacios. Completed at 1 site in Spain. Per ClinicalTrials.gov, last updated 2018-05-11.
Sponsored by Dr. Santiago Palacios · Observational
Observational study about quality of life in postmenopausal women taking coenzyme Q compared to another group of women of the same age who do not take it
Observational study to evaluate the subjective assessment performed by healthy postmenopausal women who are taking coenzyme Q for 3 months, compared with other groups of the same characteristics that do not take it
Dr. Santiago Palacios is the lead sponsor of 4 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Healthy postmenopausal woman between 45 and 65 years
Inclusion Criteria:
Exclusión Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).
Postmenopausal
Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Women who are taking coenzyme Q and who will continue taking it for 3 months
Dietary Supplement: Coenzima Q - QubiquinolCoenzyme Q - Qubiquinol
Women who are not taking coenzyme Q and who will not take it in the next 3 months
Patients in the active group will take one tablet a day orally
Change from Baseline Quality of Life at 3 months
To evaluate the quality of life in healthy postmenopausal women who are taking Coenzyme Q-Ubiquinol for 3 months in comparison with another group that does not take them. The Cervantes Health-Related Quality of Life scale for menopause will be used for this outcome. In that scale next to the 0 and the 5 there are words that describe two opposite answers to the question. Between the 0 and the 5 there are also four boxes numbered 1 to 4. The participants should answer the questions by checking the box that best represents what they think and feel. In other words, they should check 5 if they are completely agree and 0 they are completely disagree. If they are not completely agree or disagree, they should check the boxes in between
Time frame: Baseline and 3 months
Change from Baseline General Health at 3 months
Health Scale Euroqol EQ-5D will be used for this outcome
Time frame: Baseline and 3 months
Change from Baseline Mood at three months
An analogic scale will be used for this outcome in wich 0 points is the best mood and 10 points is worst mood
Time frame: Baseline and 3 months
Change from Baseline Cramps at three months
To assess changes in cramps in patients who had them, a general questionnaire about Cramps will be used to assess mainly the intensity and frequency of crambs. Regarding the intensity 0 is the lower pain and 10 is the worst pain
Time frame: Baseline and 3 months
Plan to share: No
No publications or documents are linked to this record.
Ran from Nov 2017 to primary completion in Mar 2018, 4 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Dr. Santiago Palacios